AJP - GI Journal of Applied Physiology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Gastrointest Liver Physiol 292: G1429-G1438, 2007. First published February 15, 2007; doi:10.1152/ajpgi.00315.2006
0193-1857/07 $8.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
292/5/G1429    most recent
00315.2006v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (1)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ohama, T.
Right arrow Articles by Ozaki, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ohama, T.
Right arrow Articles by Ozaki, H.

NEUROREGULATION AND MOTILITY

Intestinal inflammation downregulates smooth muscle CPI-17 through induction of TNF-{alpha} and causes motility disorders

Takashi Ohama,1 Masatoshi Hori,1 Eiichi Momotani,2 Yoichiro Iwakura,3 Fengling Guo,4 Hiroko Kishi,4 Sei Kobayashi,4 and Hiroshi Ozaki1

1Department of Veterinary Pharmacology, Graduate School of Agriculture and Life Sciences, The University of Tokyo, Tokyo; 2Paratuberculosis and Inflammatory Bowel Disease Research Team, National Institute of Animal Health, Tsukuba; 3Center for Experimental Medicine, Institute of Medical Science, The University of Tokyo, Tokyo; and 4Department of Molecular Physiology and Medical Bioregulation, Yamaguchi University Graduate School of Medicine, Yamaguchi, Japan

Submitted 18 July 2006 ; accepted in final form 26 January 2007

Motility disorders are frequently observed in intestinal inflammation. We previously reported that in vitro treatment of intestinal smooth muscle tissue with IL-1beta decreases the expression of CPI-17, an endogenous inhibitory protein of smooth muscle serine/threonine protein phosphatase, thereby inhibiting contraction. The present study was performed to examine the pathophysiological importance of CPI-17 expression in the motility disorders by using an in vivo model of intestinal inflammation and to define the regulatory mechanism of CPI-17 expression by proinflammatory cytokines. After the induction of acute ileitis with 2,4,6,-trinitrobenzensulfonic acid, CPI-17 expression declined in a time-dependent manner. This decrease in CPI-17 expression was parallel with the reduction of cholinergic agonist-induced contraction of smooth muscle strips and sensitivity of permeabilized smooth muscle fibers to Ca2+. Among the various proinflammatory cytokines tested, TNF-{alpha} and IL-1beta were observed to directly inhibit CPI-17 expression and contraction in cultured rat intestinal tissue. Moreover, both TNF-{alpha} and IL-1beta inhibited CPI-17 expression and contraction of smooth muscle tissue isolated from wild-type and IL-1{alpha}/beta double-knockout mice. However, IL-1beta treatment failed to inhibit CPI-17 expression and contraction in TNF-{alpha} knockout mice. In beta-escin-permeabilized ileal tissues, pretreatment with anti-phosphorylated CPI-17 antibody inhibited the carbachol-induced Ca2+ sensitization in the presence of GTP. These findings suggest that CPI-17 was downregulated during intestinal inflammation and that TNF-{alpha} plays a central role in this process. Downregulation of CPI-17 may play a role in motility impairments in inflammation.

smooth muscle contraction; tumor necrosis factor-{alpha}



Address for reprint requests and other correspondence: H. Ozaki, Dept. of Veterinary Pharmacology, Graduate School of Agriculture and Life Sciences, The Univ. of Tokyo, Yayoi 1-1-1, Bunkyo-ku, Tokyo 113-8657, Japan (e-mail: aozaki{at}mail.ecc.u-tokyo.ac.jp)




This article has been cited by other articles:


Home page
Mol. Pharmacol.Home page
E. Ihara, P. L. Beck, M. Chappellaz, J. Wong, S. A. Medlicott, and J. A. MacDonald
Mitogen-Activated Protein Kinase Pathways Contribute to Hypercontractility and Increased Ca2+ Sensitization in Murine Experimental Colitis
Mol. Pharmacol., May 1, 2009; 75(5): 1031 - 1041.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Gastrointest. Liver Physiol.Home page
T. Ohama, M. Okada, T. Murata, D. L. Brautigan, M. Hori, and H. Ozaki
Sphingosine-1-phosphate enhances IL-1{beta}-induced COX-2 expression in mouse intestinal subepithelial myofibroblasts
Am J Physiol Gastrointest Liver Physiol, October 1, 2008; 295(4): G766 - G775.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
W. Hu, S. Mahavadi, F. Li, and K. S. Murthy
Upregulation of RGS4 and downregulation of CPI-17 mediate inhibition of colonic muscle contraction by interleukin-1
Am J Physiol Cell Physiol, December 1, 2007; 293(6): C1991 - C2000.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2007 by the American Physiological Society.